Elevated Serum Tryptase and Endothelin in Patients with ST Segment Elevation Myocardial Infarction: Preliminary Report

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">STEMI anterior</td><td align="center">15 (45,5%)</td></tr><tr><td align="left">STEMI inferior</td><td align="center">17 (51,5%)</td></tr><tr><td align="left">STEMI lateral</td><td align="center">1 (3%)</td></tr><tr><td align="left">History of previous MI</td><td align="center">1 (3%)</td></tr><tr><td align="left">Family history of CAD</td><td align="center">8 (24,2%)</td></tr><tr><td align="left">Hypertension</td><td align="center">13 (39,4%)</td></tr><tr><td align="left">Diabetes</td><td align="center">5 (15,2%)</td></tr><tr><td align="left">LVEF [%]</td><td align="center">43,8 ± 9,6</td></tr><tr><td align="left">REF-heart failure</td><td align="center">5 (15,2%)</td></tr><tr><td align="left">3vCAD</td><td align="center">8 (24,2%)</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td>BMI: body mass index; STEMI: ST segment elevation myocardial infarction; MI: myocardial infarction; CAD: coronary artery disease; LVEF: left ventricle ejection fraction; REF: reduced ejection fraction; 3vCAD: three-vessel coronary artery disease.<br/></td></tr></table>

The clinical data of 33 patients with STEMI.

Mediators of Inflammation

tab1

Table 1

Table 1: Elevated Serum Tryptase and Endothelin in Patients with ST Segment Elevation Myocardial Infarction: Preliminary Report 